In sum, our in vivo results suggest that CAR4 T cells mostly eliminate tumors remotely in an IFN-γ-dependent mechanism and to a lesser extent during direct tumor cell contact in a perforin-dependent manner. The gene discussed is PRF1; the disease is neoplasm.